VERTEBRAL METASTASES - A CRITICAL APPRECIATION OF THE PREOPERATIVE PROGNOSTIC TOKUHASHI SCORE IN A SERIES OF 71 CASES

Citation
Ea. Enkaoua et al., VERTEBRAL METASTASES - A CRITICAL APPRECIATION OF THE PREOPERATIVE PROGNOSTIC TOKUHASHI SCORE IN A SERIES OF 71 CASES, Spine (Philadelphia, Pa. 1976), 22(19), 1997, pp. 2293-2298
Citations number
21
Categorie Soggetti
Orthopedics,"Clinical Neurology
ISSN journal
03622436
Volume
22
Issue
19
Year of publication
1997
Pages
2293 - 2298
Database
ISI
SICI code
0362-2436(1997)22:19<2293:VM-ACA>2.0.ZU;2-D
Abstract
Study Design. The utility of the Tokuhashi score was assessed in a ret rospective study in 71 patients with vertebral metastases. Objectives. To study the importance of the site of the primary tumor as a paramet er in the preoperative prognostic Tokuhashi score. Summary of Backgrou nd Data. A preoperative score composed of six parameters, each rated f rom zero to two, has been proposed by Tokuhashi for the prognostic ass essment of patients with metastases to the spine. Methods. Seventy-one patients with vertebral metastases were studied. There were 34 cases of thyroid cancer metastases, 28 cases of renal cancer metastases, and nine cases of metastases of unknown origin. In each patient, a local and a systemic tumor search were performed. Patients were divided into groups based on the primary site of the tumor, and each group was ana lyzed separately. Results. In cases of vertebral metastases of thyroid cancers, surgery to excise single metastases was found to provide goo d results, as was palliative surgery of multiple metastases. Vertebral metastases of renal tumors were rarely single, and the results of pal liative surgery were less satisfactory. Vertebral metastases of unknow n primary tumors had a poor outcome, regardless of whether surgery was excisional or palliative. The median survival period in patients with metastases of unknown primary tumors was significantly shorter than t hat in patients with renal or thyroid cancer metastases. Conclusion. T he Tokuhashi preoperative score is successful as a prognostic tool. Ho wever, it attributes the same one-point rating to metastases of renal cancer and to those of unknown primary tumors. In the case of metastas es of unknown primary tumors, this rating is too high and should be re duced to 0.